Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Warner-Lambert Company LLC v Apotex Pty Ltd [2014] FCA 241 Citation: Warner-Lambert Company LLC v Apotex Pty Ltd [2014] FCA 241
Parties: WARNER-LAMBERT COMPANY LLC, PF PRISM CV, PFIZER IRELAND PHARMACEUTICALS, PFIZER ASIA PACIFIC PTE LTD and PFIZER AUSTRALIA PTY LTD ACN 008 422 348 v APOTEX PTY LTD ACN 096 916 148
File number(s): NSD 199 of 2014
Judge(s): GRIFFITHS J
Date of judgment: 18 March 2014
Catchwords: PATENTS – application by patentee for interlocutory injunction restraining generic supplier from selling, supplying, soliciting or advertising its generic version of drug – patentee seeking interlocutory injunction pending final hearing – whether prima facie case – balance of convenience INTERLOCUTORY INJUNCTION – whether prima facie case – balance of convenience
Legislation: National Health Act 1953 (Cth) Patents Act 1990 (Cth) s 117 Therapeutic Goods Act 1989 (Cth)
Cases cited: Apotex Pty Ltd v AstraZeneca AB (No 3) (2012) 95 IPR 581; [2012] FCA 265 Apotex Pty Ltd v AstraZeneca AB (No 4) (2013) 100 IPR 285; [2013] FCA 162 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 304 ALR 1; [2013] HCA 50 Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd (2013) 100 IPR 240; [2013] FCAFC 17 GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Ltd (2013) 103 IPR 487; [2013] FCAFC 102 Pharmacia Italia S.p.A v Interpharma Pty Ltd (2005) 67 IPR 397; [2005] FCA 1675 Samsung Electronics Co Ltd v Apple Inc (2011) 286 ALR 257; [2011] FCAFC 156
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate